Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alnylam Finds Partner For Liver Cancer Program In China’s Ascletis

Jul 13 2012

Related Content

Alnylam Shifts To Product-Focused Strategy As RNAi Platform Takes A Hit

Jan 17 2011

Ascletis Raises $100MM To Deploy Its U.S.-China Hybrid Drug Development Model,

Apr 06 2011

Alnylam's Liver Cancer RNAi Program Enters The Clinic

Apr 01 2009

Alnylam CEO John Maraganore: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)

Jul 06 2012

Alnylam CEO John Maraganore – An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

Jul 05 2012

Related Companies

Alnylam Pharmaceuticals Inc.

Ascletis Pharma, Inc.

Onyx Pharmaceuticals, Inc.

Bayer AG

Roche Holding AG

Arrowhead Pharmaceuticals, Inc.

Additional Topics

China Asia Pacific United States Deals Platform Technologies Strategy BioPharmaceutical

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window